Skip to main content
Fig. 1 | Virology Journal

Fig. 1

From: Effect of 48-week pegylated interferon α-2a or nucleos(t)ide analogue therapy on renal function in Chinese patients with chronic hepatitis B

Fig. 1

The rates corresponding to virological, biochemical, and serological responses to anti-HBV agents. a Rate of virological response (undetectable HBV DNA) at 48 weeks of therapy. b Rate of biochemical response (ALT normalization) at 48 weeks of therapy. c Rate of serologic response (HBeAg loss) at 48 weeks of therapy. d Rate of serologic response (HBeAg/anti-HBe seroconversion) at 48 weeks of therapy

Back to article page

Virology Journal

ISSN: 1743-422X